Profile
Presently, Russell P. Wilson holds the position of Senior Vice President-Business Development for Novavax, Inc. He previously occupied the position of Chief Financial Officer & Vice President at Supernus Pharmaceuticals, Inc., Chief Financial Officer, Secretary & Senior VP at Intercell USA, Inc. and General Counsel at North American Vaccine, Inc. He received an MBA and a graduate degree from the University of Virginia and an undergraduate degree from Princeton University.
Former positions of Russell Wilson
Companies | Position | End |
---|---|---|
NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | 27/03/2012 |
IOMAI CORPORATION | Director of Finance/CFO | 31/07/2008 |
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | General Counsel | 31/12/1999 |
SUPERNUS PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Training of Russell Wilson
University of Virginia | Graduate Degree |
Princeton University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
NOVAVAX, INC. | Health Technology |
SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Health Technology |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
- Stock Market
- Insiders
- Russell Wilson